Robert Ho
Net Worth
Last updated:
What is Robert Ho net worth?
The estimated net worth of Mr. Robert Ho is at least $1,960,718 as of 17 Mar 2021. He has earned $71,558 from insider trading and has received compensation worth at least $1,889,160 in Neoleukin Therapeutics, Inc..
What is the salary of Robert Ho?
Mr. Robert Ho salary is $472,290 per year as Chief Financial Officer in Neoleukin Therapeutics, Inc..
How old is Robert Ho?
Mr. Robert Ho is 49 years old, born in 1976.
What stocks does Robert Ho currently own?
As insider, Mr. Robert Ho owns shares in one company:
| Company | Title | Shares | Price per share | Total value |
|---|---|---|---|---|
| Neoleukin Therapeutics, Inc. (NLTX) | Chief Financial Officer | 21,503 | $0 | $0 |
What does Neoleukin Therapeutics, Inc. do?
Neoleukin Therapeutics, Inc., a biopharmaceutical company, develops immunotherapies for cancer, inflammation, and autoimmunity disorders using protein design technology. The company's lead product candidate is NL-201, a de novo protein designed to mimic the therapeutic activity of the cytokines interleukin (IL)-2/IL-15 for the treatment of various types of cancer, including renal cell carcinoma and melanoma. The company was formerly known as Aquinox Pharmaceuticals, Inc. and changed its name to Neoleukin Therapeutics, Inc. in August 2019. Neoleukin Therapeutics, Inc. was founded in 2003 and is headquartered in Seattle, Washington.
Robert Ho insider trading
Neoleukin Therapeutics, Inc.
Mr. Robert Ho has made only one insider trade in 2021, according to the Form 4 filled with the SEC. He sold 6,497 units of NLTX stock worth $71,558 on 17 Mar 2021.
As of 17 Mar 2021 he still owns at least 21,503 units of NLTX stock.
Neoleukin Therapeutics key executives
Neoleukin Therapeutics, Inc. executives and other stock owners filed with the SEC:
- Dr. Jonathan G. Drachman (63) Chief Executive Officer, Pres & Director
- Mr. Robert Ho (49) Chief Financial Officer